Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival.
Namii
Y
Y
Department of Surgery II, Nagoya University School of Medicine, Japan.
Hayashi
S
S
Yokoyama
I
I
Kobayashi
T
T
Yasutomi
M
M
Nagasaka
T
T
Uchida
K
K
Hamada
H
H
Takagi
H
H
D000069594:Abatacept; D000256:Adenoviridae; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000096:biosynthesis* / Q000235:genetics; D060908:CTLA-4 Antigen; D015316:Genetic Therapy; D005822:Genetic Vectors; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D011994:Recombinant Proteins / Q000096:biosynthesis; D014184:Transplantation, Homologous; D001616:beta-Galactosidase / Q000096:biosynthesis
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556708:Ctla4 protein, rat; D006649:Histocompatibility Antigens; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; C038353:histocompatibility antigens RT, rat; D000069594:Abatacept; D001616:beta-Galactosidase